U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
189181189181Kidney and Liver Transplantation in People With HIVCompletedNo Results AvailableHIV Infections|Kidney Disease|Liver Diseasehttps://ClinicalTrials.gov/show/NCT00074386
189182189182The Research Registry for Neonatal LupusRecruitingNo Results AvailableNeonatal Lupus|Systemic Lupus Erythematosus|Sjogren's Syndrome|Congenital Heart BlockOther: No intervention; observationalhttps://ClinicalTrials.gov/show/NCT00074373
189183189183The Effect of Ethanol on Brain ActivityCompletedNo Results AvailableHealthyhttps://ClinicalTrials.gov/show/NCT00074360
189184189184TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade GliomaTerminatedNo Results AvailableBrain and Central Nervous System TumorsBiological: TGFa-PE38 immunotoxin|Procedure: conventional surgeryhttps://ClinicalTrials.gov/show/NCT00074334
189185189185Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: irinotecan hydrochloride|Drug: oxaliplatin|Drug: capecitabine|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00074321
189186189186Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced CancersCompletedNo Results AvailableRecurrent Melanoma|Stage III Melanoma|Stage IV Melanoma|Unspecified Adult Solid Tumor, Protocol SpecificDrug: imatinib mesylate|Biological: bevacizumab|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00074308
189187189187S0310: Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung CancerTerminatedNo Results AvailableLung CancerBiological: GVAX lung cancer vaccinehttps://ClinicalTrials.gov/show/NCT00074295
189188189188Pentostatin, Cyclophosphamide, and Rituximab Followed By Lenalidomide in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic LeukemiaRecruitingNo Results AvailableLeukemiaBiological: filgrastim|Biological: pegfilgrastim|Biological: rituximab|Drug: cyclophosphamide|Drug: lenalidomide|Drug: pentostatinhttps://ClinicalTrials.gov/show/NCT00074282
189189189189Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Metastatic Breast CancerTerminatedHas ResultsBreast CancerBiological: anti-thymocyte globulin|Biological: filgrastim|Biological: graft-versus-tumor induction therapy|Biological: therapeutic allogeneic lymphocytes|Drug: cyclosporine|Drug: fludarabine phosphate|Drug: melphalan|Drug: methotrexate|Procedure: peripheral blood stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00074269
189190189190CC-8490 in Treating Patients With Recurrent or Refractory High-Grade GliomasCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: CC-8490https://ClinicalTrials.gov/show/NCT00074243
189191189191Vaccine Therapy in Treating Patients With Stage IV Cutaneous MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: Autologous Dendritic Cells loaded with MAGE-A3, MelanA and Survivinhttps://ClinicalTrials.gov/show/NCT00074230
189192189192Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: carboplatin|Drug: docetaxel|Drug: gemcitabine hydrochloridehttps://ClinicalTrials.gov/show/NCT00074204
189193189193Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS LymphomaCompletedNo Results AvailableLymphomaDrug: cytarabine|Drug: dexamethasone|Drug: lomustine|Drug: methotrexate|Drug: procarbazine hydrochloridehttps://ClinicalTrials.gov/show/NCT00074191
189194189194Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS LymphomaCompletedNo Results AvailableLymphomaBiological: filgrastim|Biological: pegfilgrastim|Drug: cyclophosphamide|Drug: cytarabine|Drug: dexamethasone|Drug: etoposide phosphate|Drug: methotrexatehttps://ClinicalTrials.gov/show/NCT00074178
189195189195Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment RegimenTerminatedHas ResultsBrain and Central Nervous System Tumors|Drug/Agent Toxicity by Tissue/Organ|Lymphoma|ThrombocytopeniaDrug: Rituxan|Drug: Cyclophosphamide|Drug: Etoposide|Drug: Etoposide phosphate|Drug: Carboplatin|Drug: Sodium thiosulfate|Drug: Neupogen|Drug: Neulasta|Drug: Cytarabinehttps://ClinicalTrials.gov/show/NCT00074165
189196189196Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast CancerActive, not recruitingHas ResultsBreast CancerDrug: chemotherapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00074152
189197189197Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast CancerWithdrawnNo Results AvailableBreast CancerDrug: cyclophosphamide|Drug: docetaxel|Drug: doxorubicin hydrochloridehttps://ClinicalTrials.gov/show/NCT00074139
189198189198Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous ChemotherapyCompletedNo Results AvailableBreast CancerDrug: amonafide dihydrochloridehttps://ClinicalTrials.gov/show/NCT00074100
189199189199Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis FungoidesCompletedNo Results AvailableLymphomaDrug: pegylated liposomal doxorubicin hydrochloridehttps://ClinicalTrials.gov/show/NCT00074087
189200189200Infliximab in Treating Patients With Myelodysplastic SyndromeCompletedNo Results AvailableMyelodysplastic SyndromesBiological: infliximabhttps://ClinicalTrials.gov/show/NCT00074074
189201189201BL22 Immunotoxin in Treating Patients Previously Treated With Cladribine for Hairy Cell LeukemiaCompletedNo Results AvailableLeukemiaDrug: BL22https://ClinicalTrials.gov/show/NCT00074048
189202189202Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host DiseaseActive, not recruitingNo Results AvailableGraft Versus Host DiseaseDrug: pentostatinhttps://ClinicalTrials.gov/show/NCT00074035
189203189203GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid TumorsCompletedNo Results AvailableRecurrent Non-small Cell Lung Cancer|Recurrent Prostate Cancer|Stage III Prostate Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer|Stage IV Prostate Cancer|Unspecified Adult Solid TumorBiological: GTI-2040|Drug: docetaxel|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00074022
189204189204Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction AdenocarcinomaCompletedNo Results AvailableGastric CancerDrug: bortezomibhttps://ClinicalTrials.gov/show/NCT00074009
189205189205Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent ChondrosarcomaCompletedHas ResultsSarcomaBiological: filgrastim|Biological: pegfilgrastim|Drug: docetaxel|Drug: gemcitabine hydrochloride|Genetic: microarray analysis|Other: laboratory biomarker analysis|Other: pharmacokinetic studyhttps://ClinicalTrials.gov/show/NCT00073983
189206189206Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical ProstatectomyTerminatedNo Results AvailableProstate CancerDrug: celecoxibhttps://ClinicalTrials.gov/show/NCT00073970
189207189207Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's LymphomaRecruitingNo Results AvailableLymphomaBiological: rituximab|Drug: cytarabine|Drug: liposomal cytarabine|Drug: methotrexate|Radiation: yttrium Y 90 ibritumomab tiuxetanhttps://ClinicalTrials.gov/show/NCT00073957
189208189208BCX-1777 in Treating Patients With Refractory CancerCompletedNo Results AvailableCancerDrug: forodesine hydrochloridehttps://ClinicalTrials.gov/show/NCT00073944
189209189209Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNo Results AvailableLymphomaBiological: filgrastim|Biological: sargramostim|Procedure: autologous bone marrow transplantation|Procedure: peripheral blood stem cell transplantation|Radiation: tositumomab and iodine I 131 tositumomabhttps://ClinicalTrials.gov/show/NCT00073931
189210189210Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNo Results AvailableAnaplastic Large Cell Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell LympDrug: cyclophosphamide|Drug: etoposide|Radiation: iodine I 131 tositumomab|Procedure: quality-of-life assessment|Procedure: peripheral blood stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00073918

* Görseller ve İçerik tekif hakkına sahip olabilir